Menu Menu

KNSA    Kiniksa Pharmaceuticals International Plc    1730430    
Income Statement
Revenue knsa-20240930x10q 112,214,000
Net Income knsa-20240930x10q -12,693,000
Profit Margin -11.31%

Balance Sheet
Current Assets 311,301,000
Assets 555,298,000
Current Liabilities 95,955,000
Liabilities 118,292,000
Equity 437,006,000
Shares Out 40,609,000

Cash Flow Statement
Operating Cash Flow 6,919,000
Investing Cash Flow -27,621,000

Market Analysis
Market Cap 1,801,753,238
Price 18.54
BVPS 10.76
PB 1.72
EPS -0.18
PS 4.01
FCF -20,702,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/28 0.35
Apr May Jun
4/23 -0.25
Jul Aug Sep
7/23 -0.06
Oct Nov Dec
10/29

Find a discrepancy? The most accurate way to find company fundamental data is to view KNSA documents filed with the SEC.


KNSA Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas